Nonocular second primary tumors after retinoblastoma: Retrospective study of 111 patients treated by electron beam radiotherapy with or without TEM

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 27, Issue 4, 2004, Pages 411-419

  Schlienger, Pierre ^a   Campana, François ^a   Vilcoq, Jacques Robert ^a   Asselain, Bernard ^a   Dendale, Rémi ^a   Desjardins, Laurence ^a   Dorval, Thierry ^a   Quintana, Erica ^a   Rodriguez, José ^a  

^a INSTITUT CURIE   (France)

Author keywords

Age at time of irradiation; Electrontherapy; Retinoblastoma; Second primary tumors; TEM

Indexed keywords

TRETAMINE;

ADOLESCENT; AGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; ELECTRON BEAM; ELECTRON THERAPY; FEMALE; FOLLOW UP; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; ONSET AGE; PARAMETER; RADIATION DOSE; RADIATION EXPOSURE; RADIATION FIELD; RETINOBLASTOMA;

ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, ADJUVANT; DOSE FRACTIONATION; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS, SECOND PRIMARY; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TRIETHYLENEMELAMINE;

EID: 3843124553     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000128861.46357.ee     Document Type: Article

References (72)

1. Abramson DH, Ronner HJ, Ellsworth RM. Second tumors in nonirradiated bilateral retinoblastoma. Am J Ophthalmol. 1979;87:624-627.
2. Velhagen K. Röntgenbehandlung des Netzhauglioms. Strahlentherapie. 1947;76:442-448.
3. Reese AB, Merriam GR, Martin HE. Treatment of bilateral retinoblastoma by irradiation and surgery. Am J Ophthalmol. 1949;32:175-190.
4. Sagerman RH, Cassady JR, Tretter P, et al. Radiation induced neoplasia following external beam therapy for children with retinoblastoma. Am J Roentgenol Radium Ther Nucl Med. 1969;105:529-535.
5. Francois J. Retinoblastoma and osteogenic sarcoma. Ophthalmologica. 1977;175:185-191.
6. Abramson DH, Ellsworth RM, Kitchin FD, et al. Second nonocular tumors in retinoblastoma survivors - are they radiation induced? Ophthalmology. 1984;91:1351-1355.
7. Alberti W, Halama J, Wannenmacher M. Tumoren im Kopfbereich. Tumoren des Auges und der Orbita. In: Scherer E, ed. Strahlentherapie. Radiologische Onkologie. Berlin, Heidelberg, New York: Springer; 1987:412-453.
8. Wong FL, Boice JD, Ambramson DH, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1977;278: 1262-1267.
9. Dollfus MA, Auvert B. Le Gliome de la Rėtine et les Pseudogliomes. Etude Clinique, Génétique et Thérapeutique. Paris: Masson; 1953.
10. Dollfus MA, Delthil S, Haye C. Sarcome crānien post- radiothérapique après traitement d'un rétinoblastome. Bull Soc Fr Ophtal. 1962;62:233-236.
11. Chavanne G, Calle R, Gricouroff L. Bone cancers induced by external irradiation: a few observations. Symposium Ossium. London, 1968:203-204.
12. HAYE C, Jammet H, Dollfus MA. L'œil et les Radiations Ionisantes. Paris: Masson; 1965:271.
13. Haye C. A propos de la survenue d'un ostéosarcome primitif chez une enfant traitée pour tumeur de la rétine. Bull Soc Ophtal Fr. 1981;1:99-100.
14. Hugonnier M. Observation anatomo-clinique d'un sarcome radio-induit après rétinoblastome bilatéral. Bull Soc Ophtal Fr. 1978;78:31-32.
15. Bataini JP, Chavanne G, Brugere J, et al. Radiothérapie dans les cancers maxillo-faciaux. Rev Stomatol Chir Maxilo-Fac. 1979;80:178-182.
16. Bataini JP, Brugere J, Chavanne G, et al. Cancers radioinduits de la sphère maxillo-faciale. In: Les Complications et Séquelles de L'irradiation des Tumeurs Cervico-faciales. Paris: Masson; 1981:266-271.
17. Oberlin O, Bernard A, Flamant F, et al. Les secondes tumeurs malignes de l'enfant: étude de 38 cas. Arch Fr Pediatr. 1984;41:241-248.
18. Schlienger P, Calle R, Haye C, et al. Sarcomes osseux et tumeurs malignes de la rétine. Bull Cancer (Paris). 1985;72:16-24.
19. Campana F, Schlienger P, Vilcoq JR. Tumeur de la rétine et 2d cancer: à propos de 7 cas d'une série de 129 ré tinoblastomes traités à l'Institut Curie. J Eur Radioth. 1986;74:94.
20. Meadows AT, D'Angio GJ, Mike V, et al. Patterns of second malignant neoplasms in children. Cancer. 1977;40:1903-1911.
21. Meadows AT, Strong LC, Li FP, et al. Bone sarcoma as a second malignant neoplasm in children: influence of radiation and genetic predisposition for the Late Effects Study Group. Cancer. 1980;46:2603-2606.
22. Meadows AT, Baum E, Fossati-Bellani F, et al. Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol. 1985;3:532-538.
23. Tucker MA, D'Angio GJ, Boice JD Jr, et al.: Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987;317: 588-593.
24. Kingston JE, Hawkins MM, Draper GJ, et al. Patterns of multiple primary tumours in patients treated for cancer during childhood. Br J Cancer. 1987;56:331-338.
25. Hawkins MM, Wilson LM, Burton HS, et al. Radiotherapy, alkylating agents and risk of bone cancer after childhood cancer. J Natl Cancer Inst. 1996;88:270-278.
26. Draper GI, Sanders BM, Kingston IE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer. 1986;53:661-671.
27. Schipper J, Alberti W. Second nonocular cancer in retinoblastoma survivors [Letter to the editor]. Ophthalmology. 1985;92:60A-62A.
28. Hille P. Spätergebnisse der Strahlentherapie bilateraler Retinoblastome unter besonderer Berücksichtigung maligner Zweitneoplasien. Essen 1940-1973. Dissertation. University of Essen, 1989.
29. De Vathaire F, Francois P, Hill C, et al. Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood. Br J Cancer. 1989;59:792-796.
30. Le Vu B, De Vathaire F, Shamsalden A, et al. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumors during childhood. Int J Cancer. 1998;77:370-377.
31. Schlienger P, Campana F, Haye C. Second non ocular tumors in a series of 111 retinoblastomas treated at Curie Institute with electrons. Presented at the IV International Symposium on Retinoblastoma, Lisbon, 1988.
32. White. Chemotherapy for retinoblastoma: where do we go from here? Opht Paed Gen. 1991;12:115-130.
33. Smith MB, Xue H, Strong L, et al. Forty year experience with 2nd malignancies after treatment of childhood cancer: analysis of outcome following the development of the 2nd malignancy. J Pediatr Surg. 1993;28:1342-1349.
34. Murphree AL, Villablanca JG, Deegan WF, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1348-1356.
35. Gallie B, Budning A, Deboer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma with out radiotherapy. Arch Ophthalmol. 1996;114:1321-1328.
36. Shields C, De Potter P, Himelstein B, et al. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114: 1330-1338.
37. Kingston JE, Hungerford JL, Madraperia SA, et al. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1339-1343.
38. Zucker JM, Desjardins L, Doz F. Retinoblastoma. Eur J Cancer. 1998;34:1045-1049.
39. Abramson DH, Frank CM. 2nd non-ocular tumors in survivors of bilateral Rb. A possible age effect on radiation-related risk. Ophthalmology. 1998;105:573-580.
40. Haye C, Schlienger P, Calle R, et al. Traitement conservateur des tumeurs de la rétine à l'Institut Curie. Bull Cancer (Paris). 1985;73:87-98.
41. Haye C, Schlienger P, Calle R, et al. Traitement conservateur des T. de la régine à l'Institut Curie. Résultats ophtalmologiques à 5 ans de 129 cas traités par disque de Stallard et électrons. Bull Cancer. 1986;73: 260-270.
42. Reese AB, Ellsworth RM. The evaluation and current concept of retinoblastoma therapy. Tr Am Acad Ophthalmol Otol. 1963;67:164-172.
43. Reese AB, Hyman G, Merriam GR, et al. Treatment of Rb by radiation and TEM. Arch Ophthalmol. 1955;53:503-513.
44. Cahan W, Wooddard H, Higinbotham N, et al. Sarcoma arising in irradiated bone: report of eleven cases. Cancer. 1948;1:3-29.
45. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology. 1998; 95:1583-1587.
46. Moll AC, Imhof SM, Bouter LM, et al. Second primary tumours in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994. Int J Cancer. 1996;67:515-519.
47. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 1958;58:457-461.
48. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
49. Regaud C, Coutard H, Monod O, et al. Radiothérapie des cancers de la région orbito-palpébrale. Résultats et techniques de l'Institut du Radium 1919-1923. Am Oculist. 1926;163-161.
50. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993;85: 1121-1128.
51. Ambramson DH. Second non-ocular cancers in retinoblastoma; a unified hypothesis. The Fraceschetti Lecture. Ophthalmic Genet. 1999;20:193-204.
52. Derkinderen DJ, Koten JW, Nagelkerke NJD, et al. Non-ocular cancer in patients with hereditary retinoblastoma and their relatives. Int J Cancer. 1988;41:499-504.
53. Moll A, Imhof S, Bouter L, et al. Second primary tumors in patients with hereditary retinoblastoma: a single register-based follow-up study. Int J Cancer. 1996;67:193-201.
54. Moller TR, Garwicz S, Barlow L, et al. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol. 2001;19:3173-3181.
55. Alsner J, Overgaard J, Olsen JH, et al. Risk of 2nd primary cancer in hereditary and non-hereditary retinoblastoma: results from a population based study with more than 40 years follow-up. ICOO 2001.
56. Traboulsi EL, Zimmerman LE, Manz HJ. Cutaneous malignant melanoma in survivors of heritable retinoblastoma. Arch Ophthamol. 1988; 106:1059-1061.
57. Kivela T. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol. 1999;17:1829-1837.
58. Paulino AC. Trilateral retinoblastoma: is the location of the intracranial tumor important? Cancer. 1999;86:135-141.
59. Moll AC, Imhof SM, Bouter LX, Tan KEW. Second primary tumors in patients with retinoblastoma. A review of the literature. Ophthalmic Genet. 1997;18:27-34.
60. Calle R, Haye C, Schlienger P. Indications et limites de l'électronthérapie en ophtalmologie. J Radiol Electr. 1970;595-600.
61. Imhof SM, Moll AC, Hofman P, et al. 2nd primary rumors in hereditary and non hereditary Rb patients treated with megavoltage external beam irradiation. Doc Ophthalmol. 1997;93:337-344.
62. Fontanesi J, Parham DM, Pratt C, et al. 2nd malignant neoplasms in children with Rb the St Jude Children's Research Hospital experience. Ophth Genet. 1995;16:105-108.
63. Pillay R, Graham-Pole J, Novak L. Successful treatment of osteogenic sarcoma developing as a 2nd cancer in childhood. Am J Pediatr Hematol Oncol. 1983;5:103-105.
64. Newton WA Jr, Meadows AT, Shimada H, et al. Bone sarcomas as second malignant neoplasms following childhood cancer. Cancer. 1991; 67:193-201.
65. Tapley N du V. The treatment of bilateral retinoblastoma with radiation and chemotherapy. In: Boniuk, ed. Ocular and Adnexal Tumours. St Louis: CV Mosby; 1964:158-170.
66. Desjardins L, Haye C, Schlienger P, et al. Second non-ocular tumours in survivors of bilateral retinoblastoma. A 30-year follow-up. Ophthalmic Paediatr Genet. 1991;12:145-148.
67. Galper S, Gelman R, Recht A, et al. 2000: 2nd non-breast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. ASTRO 2000.
68. Fowble B, Hanlon A, Freedman G. 2nd cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys. 2001;51:679-690.
69. Heyn R, Haeberlen V, Newton WA, et al. Second malignant neoplasms in children treated for rhabdomyosarcoma. J Clin Oncol. 1993;11:262-270.
70. Char DH. Discussion in 2nd non ocular tumors in survivor of bilateral retinoblastoma. Ophthalmology. 1998;105:579-580.
71. Moll AC, Imhof SM, Schouten-Van Meeterent AYN. Second primary tumors in hereditary Rb: a register-based study, 1945-1997. Is there an age-effect on radiation related risk? Ophthalmology. 2001;108:1109-1114.
72. Chauveinc L, Mosseri V, Quintana E, et al. Osteosarcoma following retinoblastoma age at onset and latency period. Ophthalmic Genet. 2001;22:77-88.